I taught BIST 502 at the FDA. This summary describes the first third of the course (although I taught the whole course) - helping me to identify aspects of the course I could improve on. As noted in the overall introduction to the Evaluations section of the Portfolio, the standard evaluation form is not formative, and so it is impossible to identify specific features to modify -even for a later term -using the standard form.  eval.summary.502.sp04.fda_first.third.doc